Search results
Results from the WOW.Com Content Network
Modernising Scientific Careers (MSC) is a UK-wide government initiative to address the training and education needs of the whole healthcare science workforce in the National Health Service (NHS). [1] The initiative won a Healthcare Innovation Award in 2013. [ 2 ]
Red or healthcare biotechnology is the application of biotechnology for the production of medicines and therapies. EuropaBio's stated goals are: promoting an innovative, coherent, and dynamic biotechnology-based industry in Europe; advocating free and open markets and the removal of barriers to competitiveness with other areas of the world;
The NHS was established within the differing nations of the United Kingdom through differing legislation, and as such there has never been a singular British healthcare system, instead there are 4 health services in the United Kingdom; NHS England, the NHS Scotland, HSC Northern Ireland and NHS Wales, which were run by the respective UK government ministries for each home nation before falling ...
Around £920m is spent on biotechnology research in the UK, around 4.5% of all private sector research and development. According to an OECD study, the UK is fourth in the world for expenditure on biotechnology research, after the USA, France and Switzerland. France spends around twice that of the UK on biotechnology.
A biomedical scientist is a scientist trained in biology, particularly in the context of medical laboratory sciences or laboratory medicine.These scientists work to gain knowledge on the main principles of how the human body works and to find new ways to cure or treat disease by developing advanced diagnostic tools or new therapeutic strategies.
Operating department practitioners are subject to specific standards of proficiency as laid out by the Health & Care Professions Council. [8] Alongside this, their professional role is also broadly defined by the College of Operating Department Practitioners (CODP)'s Scope of Practice document as published by the college in 2009.
The European Federation of Biotechnology (EFB) was established by European scientists in 1978.It is a non-profit federation of national biotechnology associations, learned societies, universities, scientific institutes, biotechnology companies and individual biotechnologists working to promote biotechnology throughout Europe and beyond.
The document, building on the 2006 Best Research for Best Health strategy, outlined the updated operational principles, core work-streams and areas of strategic focus of the NIHR. [25] Their work-streams include funding research for the NHS, public and global health and social care ; investing in expertise and facilities; and involving patients ...